Evidence map›Paper›PMID 37325051›Full record

ArticleJournal of Cancer2023

Maïwenn Kerdreux, Sofia Edin, Thyra Löwenmark, Vicky Bronnec, Anna Löfgren-Burström, Carl Zingmark, Ingrid Ljuslinder, Richard Palmqvist, Agnes Ling

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Gut microbes · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. The Presence and Tissue Distribution ofInternational journal of dentistry · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Multiomics profiling reveals thatFrontiers in cellular and infection microbiology · 2025
    Article
  16. The Oral Microbiome and Cancer.Advances in experimental medicine and biology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maïwenn KerdreuxDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Sofia EdinDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Thyra LöwenmarkDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Vicky BronnecDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Anna Löfgren-BurströmDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Carl ZingmarkDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Ingrid LjuslinderDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Richard PalmqvistDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Agnes LingDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbiota dysbiosis may affect both the development and progression of colorectal cancer (CRC). Large metagenomic studies have highlighted specific oral bacteria linked to CRC including

Indexed as

colorectal cancermicrobiotaPorphyromonas gingivalissurvival

Identifiers

PMID37325051
PMCPMC10266249
OpenAlexW4380871334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.